Mass Spectrometry-Based Profiling of Histone Post-Translational Modifications in Uveal Melanoma Tissues, Human Melanocytes, and Uveal Melanoma Cell Lines - A Pilot Study.
Journal Information
Full Title: Invest Ophthalmol Vis Sci
Abbreviation: Invest Ophthalmol Vis Sci
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Ophthalmology
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"the ms data have been deposited to the proteomexchange consortium via the pride partner repository with the dataset identifier pxd043551."
"Disclosure: M.C. Herwig-Carl, None; A. Sharma, None; V. Tischler, None; N. Pelusi, None; K.U. Loeffler, None; F.G. Holz, Acucela (C, F), Alexion (C), Alzheon (C), Allergan (F), Apellis (C, F), Astellas (C), Bayer (C, F), Boehringer-Ingelheim (C), Bioeq/Formycon (F, C), CenterVue (F), Roche/Genentech (C, F), Geuder (C, F), Graybug (C), Gyroscope (C), Heidelberg Engineering (C, F), IvericBio (C, F), Janssen (C), Kanghong (C, F), LinBioscience (C), NightStarX (F), Novartis (C, F), Optos (F), Oxurion (C), Pixium Vision (C, F), Oxurion (C), Stealth BioTherapeutics (C), Zeiss (F, C), GRADE Reading Center (O); M. Zeschnigk, None; S. Landreville, None; C. Auw-Haedrich, None; R. Noberini, None; T. Bonaldi, None"
"Supported by EPIC-XS, project number 823839, funded by the Horizon 2020 programme of the European Union and Open Access Publication Fund of the University of Bonn."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025